HC Wainwright Brokers Reduce Earnings Estimates for PTGX
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) – Research analysts at HC Wainwright lowered their Q2 2025 earnings estimates for shares of Protagonist Therapeutics in a report released on Wednesday, May 7th. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings per share of ($0.67) for the quarter, down from their […]
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) – Research analysts at HC Wainwright lowered their Q2 2025 earnings estimates for shares of Protagonist Therapeutics in a report released on Wednesday, May 7th. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings per share of ($0.67) for the quarter, down from their […]
